- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 23-05-2025: Press Release
23-05-2025 | 05:18 pm
23-05-2025 | 05:18 pm
Zydus has announced a board meeting to review the financial results for the quarter and half-year. It received final USFDA approval for Isotretinoin Capsules (10-40 mg) at its Ahmedabad plant. These capsules had US sales of USD 115.4 million (IQVIA MAT March 2025), strengthening Zydus’ portfolio with 427 total US approvals and 492 ANDA filings since FY 2003-04, supporting steady growth in its US generics pipeline.
No comments yet. Be the first to comment!